HOTH News and Press, Hoth Therapeutics Inc. From 04/11/22

The development-stage pharmaceutical company Hoth Therapeutics (NASDAQ:HOTH) followed up its impressive preclinical data for its investigational cancer therapy, HT-KIT with the start of an underwritten public offering of common stock on Monday. Following the announcement, the shares of the Ne...

Gainers: Veru (VERU) +196%. Hoth Therapeutics (HOTH) +126%. Altamira Therapeutics (CYTO) +54%. Iveda Solutions (IVDA) +37%. VNET Group (VNET) +30%. SailPoint Technologies Holdings (SAIL) +29%. Castor Maritime (CTRM) +25%. Datto Holding (MSP) +21%. Axcella Health (AXLA) +16%. TScan Therapeutic...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips SoFi Technologies (NASDAQ: SOFI ) stock isn’t doing so well on Monday after the stock dropped to a new 52-week low. Source: rafapress / Shutterstock.com So what’s behind this fall for SOFI stock? A...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Warner Bros. Discovery (NASDAQ: WBD ) stock is on the move today following the merger between Warner Bros. and Discovery last week. Source: Ingus Kruklitis / Shutterstock.com The merger between Warner Bros. an...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Hoth Therapeutics (NASDAQ: HOTH ) stock is rising higher on Monday after the biopharmaceutical company provided an update on HT-KIT. Source: Bukhta Yurii / Shutterstock.com HT-KIT is the company’s novel...

NEW YORK, April 11, 2022 (GLOBE NEWSWIRE) -- Wall Street Reporter, the trusted name in financial news since 1843, has published reports on the latest comments and insights from CEO’s of: Hoth Therapeutics (NASDAQ: HOTH), Nova Mentis Life Sciences (OTC: NMLSF) (CSE: NOVA), Tonix Pharm...

What to Know About Trading Penny Stocks on April 11th With another week of trading penny stocks getting off to an interesting start, there is a lot for investors to know. Considering that there is still an extremely high amount of volatility in the stock market, investors need to be on ...

Hoth Therapeutics (NASDAQ:HOTH) has gained ~135% in the pre-market Monday after the development-stage pharmaceutical company announced encouraging preclinical data for its investigational cancer therapy, HT-KIT. According to the company, a team of researchers who were part...

Hoth Therapeutics mRNA Frame-Shifting Therapeutic, HT-KIT, Proves Effective Against Aggressive Cancer Cells PR Newswire Treatment with HT-KIT prevented cancer cell growth and induced death in neoplastic mast cells over 72 hours HT-KIT inhibits tumor growth and ...

Hoth Therapeutics Announces Pipeline Presentation at the 2022 BIO International Convention PR Newswire Dr. Stefanie Johns , Chief Scientific Officer, will present updates on the Hoth Therapeutics Pipeline, including new proof-of-concept data for HT-ALZ, a novel Alz...